Clinical Trial Detail

NCT ID NCT02659540
Title A Pilot Study to Evaluate the Safety and Efficacy of Combination Checkpoint Blockade Plus External Beam Radiotherapy in Subjects With Stage IV Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ludwig Institute for Cancer Research



Ipilimumab + Nivolumab

Age Groups: adult

No variant requirements are available.